<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39379362</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Coronavirus envelope protein activates TMED10-mediated unconventional secretion of inflammatory factors.</ArticleTitle><Pagination><StartPage>8708</StartPage><MedlinePgn>8708</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8708</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-024-52818-0</ELocationID><Abstract><AbstractText>The precise cellular mechanisms underlying heightened proinflammatory cytokine production during coronavirus infection remain incompletely understood. Here we identify the envelope (E) protein in severe coronaviruses (SARS-CoV-2, SARS, or MERS) as a potent inducer of interleukin-1 release, intensifying lung inflammation through the activation of TMED10-mediated unconventional protein secretion (UcPS). In contrast, the E protein of mild coronaviruses (229E, HKU1, or OC43) demonstrates a less pronounced effect. The E protein of severe coronaviruses contains an SS/DS motif, which is not present in milder strains and facilitates interaction with TMED10. This interaction enhances TMED10-oligomerization, facilitating UcPS cargo translocation into the ER-Golgi intermediate compartment (ERGIC)-a pivotal step in interleukin-1 UcPS. Progesterone analogues were identified as compounds inhibiting E-enhanced release of proinflammatory factors and lung inflammation in a Mouse Hepatitis Virus (MHV) infection model. These findings elucidate a molecular mechanism driving coronavirus-induced hyperinflammation, proposing the E-TMED10 interaction as a potential therapeutic target to counteract the adverse effects of coronavirus-induced inflammation.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Lijingyao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Xinyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaochun</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-0793-9339</Identifier><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Liang</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7371-2039</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Peihui</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6853-2423</Identifier><AffiliationInfo><Affiliation>Key Laboratory for Experimental Teratology of Ministry of Education and Advanced Medical Research Institute, Meili Lake Translational Research Park, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Boxue</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5830-0669</Identifier><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Min</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0887-9147</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Membrane Biology, Tsinghua University, Beijing, 100084, China. zhangmin143@mail.tsinghua.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China. zhangmin143@mail.tsinghua.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32370728</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant><Grant><GrantID>32200553</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant><Grant><GrantID>92254302</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant><Grant><GrantID>32225013</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant><Grant><GrantID>32130023</GrantID><Agency>National Natural Science Foundation of China (National Science Foundation of China)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086968">Coronavirus Envelope Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006517" MajorTopicYN="Y">Murine hepatitis virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086968" MajorTopicYN="N">Coronavirus Envelope Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006056" MajorTopicYN="N">Golgi Apparatus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39379362</ArticleId><ArticleId IdType="pmc">PMC11461611</ArticleId><ArticleId IdType="doi">10.1038/s41467-024-52818-0</ArticleId><ArticleId IdType="pii">10.1038/s41467-024-52818-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A. &amp; Ng, L. F. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol.20, 363–374 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wit, E., Van Doremalen, N., Falzarano, D. &amp; Munster, V. J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol.14, 523–534 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097822</ArticleId><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y.-y, Li, B.-r &amp; Ning, B.-t The comparative immunological characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 coronavirus infections. Front. Immunol.11, 2033 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7457039</ArticleId><ArticleId IdType="pubmed">32922406</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med.26, 1636–1643 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, B. et al. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res.31, 847–860 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8190750</ArticleId><ArticleId IdType="pubmed">34112954</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, L. et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduct. Target. Ther.5, 128 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381863</ArticleId><ArticleId IdType="pubmed">32712629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, B., Huang, S. &amp; Yin, L. The cytokine storm and COVID‐19. J. Med. Virol.93, 250–256 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, M. et al. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology160, 261–268 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283723</ArticleId><ArticleId IdType="pubmed">32460357</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin, C. et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis.71, 762–768 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani, A., Dinarello, C. A., Molgora, M. &amp; Garlanda, C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity50, 778-795, 10.1016/j.immuni.2019.03.012 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7174020</ArticleId><ArticleId IdType="pubmed">30995499</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S. &amp; Masumoto, J. The role of interleukin-1 in general pathology. Inflamm. regeneration39, 1–16 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551897</ArticleId><ArticleId IdType="pubmed">31182982</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesenauer, B. &amp; Paczesny, S. The ST2/IL-33 axis in immune cells during inflammatory diseases. Front. Immunol.8, 475 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5402045</ArticleId><ArticleId IdType="pubmed">28484466</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovic, S. S. et al. IL 33 correlates with COVID-19 severity, radiographic and clinical finding. Front. Med.8, 749569 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669591</ArticleId><ArticleId IdType="pubmed">34917631</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti, P. et al. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy. J. Biol. Regul. Homeost. Agents34, 1971–1975 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33016027</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaremi, S. et al. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19. Inflamm. Res.71, 923–947 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9243884</ArticleId><ArticleId IdType="pubmed">35751653</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteleone, M., Stow, J. L. &amp; Schroder, K. Mechanisms of unconventional secretion of IL-1 family cytokines. Cytokine74, 213–218 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25922276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M. et al. A translocation pathway for vesicle-mediated unconventional protein secretion. Cell181, 637–652.e615 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32272059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M. &amp; Schekman, R. Unconventional secretion, unconventional solutions. Science340, 559–561 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23641104</ArticleId></ArticleIdList></Reference><Reference><Citation>Evavold, C. L. et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity48, 35–44.e36 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5773350</ArticleId><ArticleId IdType="pubmed">29195811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayagaki, N. et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature526, 666–671 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26375259</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature526, 660–665 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26375003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, W. et al. Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion. Nat. Immunol.23, 1021–1030 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11345751</ArticleId><ArticleId IdType="pubmed">35794369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, L. et al. Intraepithelial mast cells drive gasdermin C-mediated type 2 immunity. Immunity57, 1056–1070.e1055 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38614091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont, N. et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J.30, 4701–4711 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243609</ArticleId><ArticleId IdType="pubmed">22068051</ArticleId></ArticleIdList></Reference><Reference><Citation>Martín-Sánchez, F. et al. Inflammasome-dependent IL-1β release depends upon membrane permeabilisation. Cell Death Differ.23, 1219–1231 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4946890</ArticleId><ArticleId IdType="pubmed">26868913</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteleone, M. et al. Interleukin-1β maturation triggers its relocation to the plasma membrane for gasdermin-D-dependent and-independent secretion. Cell Rep.24, 1425–1433 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30089254</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, S. et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol.24, 490–502 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125511</ArticleId><ArticleId IdType="pubmed">27012512</ArticleId></ArticleIdList></Reference><Reference><Citation>He, F., Deng, Y. &amp; Li, W. Coronavirus disease 2019: What we know? J. Med. Virol.92, 719–725 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228340</ArticleId><ArticleId IdType="pubmed">32170865</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung, T. S. &amp; Liu, D. X. Human coronavirus: host-pathogen interaction. Annu. Rev. Microbiol.73, 529–557 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31226023</ArticleId></ArticleIdList></Reference><Reference><Citation>Stertz, S. et al. The intracellular sites of early replication and budding of SARS-coronavirus. Virology361, 304–315 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7103305</ArticleId><ArticleId IdType="pubmed">17210170</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeman, D. &amp; Fielding, B. C. Coronavirus envelope protein: current knowledge. Virol. J.16, 1–22 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537279</ArticleId><ArticleId IdType="pubmed">31133031</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatagopalan, P., Daskalova, S. M., Lopez, L. A., Dolezal, K. A. &amp; Hogue, B. G. Coronavirus envelope (E) protein remains at the site of assembly. Virology478, 75–85 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4550588</ArticleId><ArticleId IdType="pubmed">25726972</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. TMED10-mediated unconventional secretion of IL-33 regulates intestinal epithelium differentiation and homeostasis. Cell Res. 1-4 10.1038/s41422-023-00891-3 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10907340</ArticleId><ArticleId IdType="pubmed">38185700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M., Kenny, S. J., Ge, L., Xu, K. &amp; Schekman, R. Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. elife4, e11205 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728131</ArticleId><ArticleId IdType="pubmed">26523392</ArticleId></ArticleIdList></Reference><Reference><Citation>Vora, S. M., Lieberman, J. &amp; Wu, H. Inflammasome activation at the crux of severe COVID-19. Nat. Rev. Immunol.21, 694–703 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8351223</ArticleId><ArticleId IdType="pubmed">34373622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, X. et al. SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1. Cell Death Differ.29, 1240–1254 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9177730</ArticleId><ArticleId IdType="pubmed">34997207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira, A. C. et al. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell death Discov.7, 43 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7919254</ArticleId><ArticleId IdType="pubmed">33649297</ArticleId></ArticleIdList></Reference><Reference><Citation>Santry, L. A. et al. AAV vector distribution in the mouse respiratory tract following four different methods of administration. BMC Biotechnol.17, 1–11 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433059</ArticleId><ArticleId IdType="pubmed">28506256</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandala, V. S. et al. Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers. Nat. Struct. Mol. Biol.27, 1202–1208 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7718435</ArticleId><ArticleId IdType="pubmed">33177698</ArticleId></ArticleIdList></Reference><Reference><Citation>Surya, W., Li, Y., Verdià-Bàguena, C., Aguilella, V. M. &amp; Torres, J. MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels. Virus Res.201, 61–66 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114494</ArticleId><ArticleId IdType="pubmed">25733052</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdiá-Báguena, C. et al. Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. Virology432, 485–494 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438407</ArticleId><ArticleId IdType="pubmed">22832120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB. Cell Discov.9, 80 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10382526</ArticleId><ArticleId IdType="pubmed">37507399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W.-A., Carreras-Sureda, A. &amp; Demaurex, N. SARS-CoV-2 infection alkalinizes the ERGIC and lysosomes through the viroporin activity of the viral envelope protein. J. Cell Sci.136, jcs260685 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10112968</ArticleId><ArticleId IdType="pubmed">36807531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Torres, J. L. et al. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology485, 330–339 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4619128</ArticleId><ArticleId IdType="pubmed">26331680</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalcinkaya, M. et al. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein. Sci. Rep.11, 24432 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709866</ArticleId><ArticleId IdType="pubmed">34952919</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Torres, J. L. et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog.10, e1004077 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4006877</ArticleId><ArticleId IdType="pubmed">24788150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pervushin, K. et al. Structure and inhibition of the SARS coronavirus envelope protein ion channel. PLoS Pathog.5, e1000511 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2702000</ArticleId><ArticleId IdType="pubmed">19593379</ArticleId></ArticleIdList></Reference><Reference><Citation>Regla-Nava, J. A. et al. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J. Virol.89, 3870–3887 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4403406</ArticleId><ArticleId IdType="pubmed">25609816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain, A., Akter, S., Rashid, A. A., Khair, S. &amp; Alam, A. R. U. Unique mutations in SARS-CoV-2 Omicron subvariants’ non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion. Microb. pathogenesis170, 105699 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356572</ArticleId><ArticleId IdType="pubmed">35944840</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature603, 693–699 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35062016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bálint, G., Vörös-Horváth, B. &amp; Széchenyi, A. Omicron: increased transmissibility and decreased pathogenicity. Signal Transduct. Target. Ther.7, 151 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077027</ArticleId><ArticleId IdType="pubmed">35525870</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto-Torres, J. L. et al. Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein. Virology415, 69–82 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4726981</ArticleId><ArticleId IdType="pubmed">21524776</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwinn, M. K. et al. CRISPR-mediated tagging of endogenous proteins with a luminescent peptide. ACS Chem. Biol.13, 467–474 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28892606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh, S. et al. β-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell183, 1520–1535.e1514 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7590812</ArticleId><ArticleId IdType="pubmed">33157038</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Q. et al. Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19. Cell host microbe29, 222–235.e224 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7762710</ArticleId><ArticleId IdType="pubmed">33388094</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, L. et al. Distinct roles of type I and type III interferons during a native murine β coronavirus lung infection. J. Virol.96, e01241–01221 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8791255</ArticleId><ArticleId IdType="pubmed">34705554</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, L. et al. Female sex hormone, progesterone, ameliorates the severity of SARS-CoV-2-caused pneumonia in the Syrian hamster model. Signal Transduct. Target. Ther.7, 47 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8844354</ArticleId><ArticleId IdType="pubmed">35165265</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, S. et al. Modulation of innate immune response to viruses including SARS-CoV-2 by progesterone. Signal Transduct. Target. Ther.7, 137 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9035769</ArticleId><ArticleId IdType="pubmed">35468896</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, S. et al. SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development. Biomed. Pharmacother., 114242 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832061</ArticleId><ArticleId IdType="pubmed">36652729</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeman, D. &amp; Fielding, B. C. Is there a link between the pathogenic human coronavirus envelope protein and immunopathology? A review of the literature. Front. Microbiol.11, 2086 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7496634</ArticleId><ArticleId IdType="pubmed">33013759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, M. et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat. Immunol.22, 829–838 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8882317</ArticleId><ArticleId IdType="pubmed">33963333</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio, F. et al. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis. Microbes Infect.22, 592–597 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473260</ArticleId><ArticleId IdType="pubmed">32891874</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai, J. et al. Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1. Nat. Commun.12, 3433 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8187709</ArticleId><ArticleId IdType="pubmed">34103506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, X. et al. Unconventional secretion of unglycosylated ORF8 is critical for the cytokine storm during SARS-CoV-2 infection. PLoS Pathog.19, e1011128 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9894554</ArticleId><ArticleId IdType="pubmed">36689483</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka, K. et al. SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer. J. Biol. Chem.298, 101724 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8832879</ArticleId><ArticleId IdType="pubmed">35157849</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, X. et al. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway. Iscience24, 102293 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7942160</ArticleId><ArticleId IdType="pubmed">33723527</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao, G. et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Developmental cell56, 427–442.e425 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832235</ArticleId><ArticleId IdType="pubmed">33422265</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji, M. et al. VMP1 and TMEM41B are essential for DMV formation during β-coronavirus infection. J. Cell Biol.221, e202112081 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9097365</ArticleId><ArticleId IdType="pubmed">35536318</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco, J. D. et al. TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2. PLoS Pathog.17, e1009599 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189496</ArticleId><ArticleId IdType="pubmed">34043740</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider, W. M. et al. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks. Cell184, 120–132.e114 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7796900</ArticleId><ArticleId IdType="pubmed">33382968</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee, S. &amp; Pahan, K. Is COVID-19 gender-sensitive? J. Neuroimmune Pharmacol.16, 38–47 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786186</ArticleId><ArticleId IdType="pubmed">33405098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. et al. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins. Signal Transduct. Target. Ther.5, 269 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670843</ArticleId><ArticleId IdType="pubmed">33203855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, X. et al. Integrated regulation of Toll-like receptor responses by Notch and interferon-γ pathways. Immunity29, 691–703 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2585039</ArticleId><ArticleId IdType="pubmed">18976936</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. A new type of ERGIC–ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis. Cell Res.32, 119–138 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461442</ArticleId><ArticleId IdType="pubmed">34561617</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, X. et al. CCT2 is an aggrephagy receptor for clearance of solid protein aggregates. Cell185, 1325–1345.e1322 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35366418</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge, L., Melville, D., Zhang, M. &amp; Schekman, R. The ER–Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis. elife2, e00947 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3736544</ArticleId><ArticleId IdType="pubmed">23930225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopera, D. et al. Structural and topographic dynamics of pulmonary histopathology and local cytokine profiles in Paracoccidioides brasiliensis conidia-infected mice. PLoS Neglected Tropical Dis.5, e1232 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3134433</ArticleId><ArticleId IdType="pubmed">21765962</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibowitz, J., Kaufman, G. &amp; Liu, P. Coronaviruses: propagation, quantification, storage, and construction of recombinant mouse hepatitis virus. Curr. Protoc. Microbiol.21, 15E. 11.11–15E. 11.46 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3119930</ArticleId><ArticleId IdType="pubmed">21538303</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>